CCI nod to merger and demerger of AMPL and AHTL
Published: Sep 24, 2025

By TIOLCorplaws News Service
The proposed combination involves the following:
a. Step 1: demerger of the identified business undertaking of Apollo Health Enterprise Limited (AHEL) (Identified Business Undertaking Demerger) into Apollo Healthtech Limited (AHTL), in accordance with a composite scheme of arrangement approved by the boards of directors and audit committees of Apollo Healthco Limited (AHL) and Keimed Private Limited (Keimed) on 27th June 2025, and AHEL and AHTL on 30 th June 2025 (Composite Scheme);
b. Step 2: merger and amalgamation of AHL with and into AHTL (AHL Merger) in accordance with the Composite Scheme;
c. Step 3: merger and amalgamation of Keimed with and into AHTL(Keimed Merger) in accordance with the Composite Scheme;
d. Step 4: listing of the equity shares of AHTL on the stock exchanges, subsequent to effectiveness of the Composite Scheme; and
e. Step 5: Acquisition of 74.5% shareholding of AMPL from existing shareholders by AHTL (AMPL Acquisition) in accordance with the applicable regulatory framework and in terms of a Share Purchase Agreement (SPA) executed between AHL, AMPL and the existing shareholders of AMPL (AMPL SPA).
AHTL is a newly incorporated company and currently does not have any activities worldwide or in India.
AHL operates the "Apollo 24/7" platform which helps users/customers to book doctor appointments and diagnostic tests. AHL also operates in the pharmacy distribution segment.
Keimed is involved in the business of: (i) wholesale sale and distribution of pharmaceutical products, OTC products, medical equipment, surgical products, scientific apparatus and equipment for hospitals and FMCG; (ii) retail sale of specialty pharmaceutical products through certain subsidiaries and (iii) marketing and sale of pharmaceutical products.